From Pharma to AGI Hype, and Developing AI in Finance: Martin Shkreli’s Journey

Gradient Dissent: Conversations on AI

Lukas Biewald에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Lukas Biewald 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

6M ago 1:30:19

MP3•에피소드 홈

In this episode of Gradient Dissent, Lukas Biewald talks with Martin Shkreli — the infamous "pharma bro" turned founder — about his path from hedge fund manager and pharma CEO to convicted felon and now software entrepreneur. Shkreli shares his side of the drug pricing controversy, reflects on his prison experience, and explains how he rebuilt his life and business after being "canceled."

They dive deep into AI and drug discovery, where Shkreli delivers a strong critique of mainstream approaches. He also talks about his latest venture in finance software, building Godel Terminal “a Vim for traders", and why he thinks the AI hype cycle is just beginning. It's a wide-ranging and candid conversation with one of the most controversial figures in tech and biotech.

Follow Martin Shkreli on Twitter

Godel Terminal: https://godelterminal.com/

Follow Weights & Biases on Twitter

https://www.linkedin.com/company/wandb

Join the Weights & Biases Discord Server:

https://discord.gg/CkZKRNnaf3

128 에피소드

#Tech #Lukas Biewald #Business #Machine Learning